Skip to content

Comparative Effects of Transcranial Alternating Current Stimulation at Different Frequencies on Children with Cognitive Impairment

Comparative Effects of Transcranial Alternating Current Stimulation at Different Frequencies on Children with Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117428
Enrollment
Unknown
Registered
2026-01-23
Start date
2026-01-31
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Global developmental delay

Interventions

Low-frequency group:Conventional rehabilitation therapy + low-frequency (6Hz) high-precision transcranial alternating current stimulation (HD-tACS)
High-Frequency Group:Conventional rehabilitation therapy + high-frequency (40Hz) high-precision transcranial alternating current stimulation (HD-tACS)
Control group:Conventional rehabilitation therapy + High-Definition Transcranial Alternating Current Stimulation (HD-tACS) (no actual electrical current)

Sponsors

The Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1 Age: 24 to 60 months; 2 Meets DSM-5 diagnostic criteria for global developmental delay; 3 GDS assessment: Scores below 75 in two or more domains, including the adaptive skills domain; 4 Parent or guardian consents to study participation, completes pre-treatment evaluations, and signs informed consent form.

Exclusion criteria

Exclusion criteria: 1 Individuals with motor disorders such as cerebral palsy or spinal cord injury; 2 Patients with severe hearing or visual impairments, or other conditions affecting assessment; 3 Those with epilepsy or other severe neurological disorders; 4 Patients with identifiable causes of developmental delay, such as postnatal encephalitis, traumatic brain injury, cerebral hemorrhage, or confirmed diagnoses of genetic metabolic disorders or neurodegenerative diseases; 5 Patients with cardiac pacemakers or other electronic implants; 6 Patients with metallic implants or intracranial metal fragments; 7 Patients who have recently undergone other brain stimulation therapies; 8 Patients with allergies or contraindications to electrical stimulation therapy.

Design outcomes

Primary

MeasureTime frame
Gesell Developmental Scale ;

Secondary

MeasureTime frame
Electroencephalogram assessment;fNIRS ;

Countries

China

Contacts

Public ContactDengna Zhu

The Third Affiliated Hospital of Zhengzhou University

zhudengna@126.com+86 152 2515 9316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026